FDA Oversight Of Clinical Trial Investigators Questioned By Rep. Bliley
FDA oversight of clinical trial investigators is questioned by the House Commerce Committee in a July 13 letter to the HHS Inspector General.
FDA oversight of clinical trial investigators is questioned by the House Commerce Committee in a July 13 letter to the HHS Inspector General.